Latest News



The bacteria Staphylococcous aureus: Capable of producing tissue healing toxins

Oct 19,2020 Source: Biotechnika   Staphylococcus aureus found in and on human body has found to have tissue healing toxin that stimulates tissue regeneration. It is a harmless bacteria that is common in one out of 4 people on mucous membrane of respiratory tract or on their skin. However, it can be pathogenic when it tends to multiply fast especially when an individual has weak immune system after an injury or an infection, leading to skin inflammation and lung infection and



COVID-19: Detection of Silent Carriers By Saliva Testing

     At Hokkaido University, Japan, scientists have shown an effective testing approach using saliva samples to identify covid-19 infected persons who have not shown any symptoms yet.      Takonari Teshima, researcher at Hokkaido University says, “Rapid detection of asymptomatic infected individuals will be critical for preventing covid-19 outbreaks in communities and hospitals.”      Testing and tracing has become ver



Stroke triggered by mosquito-borne viruses

          The link between neurological disease and infection caused by Zika and Chikungunya viruses have been investigated by the University of Liverpool researchers and Brazilian Collaborators. These viruses most probably spread in tropical regions such as Brazil and India causing large outbreaks of rash and fever.           Study was done on 201 adults with onset of neurological disease to explain neurological featur



Marijuana risk during pregnancy

  Cannabis, Marijuana, is commonly used as drug by people of reproductive age. The rise in use of marijuana takes place and at the same time THC percentage in drug has increased. THC is the main psychoactive ingredient in cannabis. The researchers have used a rat model and human placental cells to show maternal exposure to THC during pregnancy which has high effect on development of organs of fetus and in placental function. Researchers have exposed a low dose of THC mimics to th



A leading coronavirus vaccine trial is on hold

Scientists urge caution in global vaccine race as AstraZeneca reports ‘adverse event’ in a person who received the Oxford vaccine. Enrolment in global trials of a leading coronavirus-vaccine candidate are on hold after a ‘suspected adverse event’ in a person who received the vaccine in the United Kingdom. Scientists say that it’s too soon to say what impact this might have on the global push to develop a vaccine, but that the news highlights the importance of